CD38 Targeted -PET/ CT for Multiple Myeloma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The objective of the study is to construct a noninvasive approach CD38 targeted PET/CT to detect tumor lesions in patients with Multiple Myeloma and to compare with FDG PET/CT.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Nowo rozpoznany szpiczak plazmocytowy lub podejrzenie nawrotu choroby
- •Pacjent poddany zarówno standardowym badaniom obrazowym (FDG PET/CT) jak i badaniu CD38 PET/CT
- •Możliwość wyrażenia świadomej zgody na udział w badaniu
✗ Disqualifies
- •Brak możliwości lub niechęć do podpisania zgody na udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
The First Affliated Hospital of Guilin Medical University
Guilin, China
Trial contact
Xingyu Mu, M.D.
Wei Fu
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/25/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.